Home › Funds › J.Safra Asset Management Corp › PPH
J.Safra Asset Management Corp position in PPH
VANECK PHARMACEUTICAL ETF
J.Safra Asset Management Corp reported holding 328,313 shares of PPH (VANECK PHARMACEUTICAL ETF) in its Q3 2026 13F filing — a position valued at US$35.9M, representing 1.56% of its reported portfolio and ranking #16 among its reported holdings. J.Safra Asset Management Corp has disclosed PPH holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How J.Safra Asset Management Corp's PPH position evolved
J.Safra Asset Management Corp first disclosed a stake in PPH in Q1 2024 at 69,525 shares (US$6.3M). The position peaked in Q3 2026 at 328,313 shares, worth US$35.9M. Across 11 filings, J.Safra Asset Management Corp increased the stake 10 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 328,313 shares valued at US$35.9M — an increase of 8,677 shares quarter over quarter.. Notable position changes include a 230% increase in Q4 2024 (shares rose 6% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 69.53K | $6.31M | New |
| Q2 2024 | 73.61K | $6.73M | Add |
| Q3 2024 | 78.76K | $7.47M | Add |
| Q4 2024 | 260.27K | $22.39M | Add |
| Q1 2025 | 268.83K | $24.50M | Add |
| Q2 2025 | 273.78K | $24.08M | Add |
| Q3 2025 | 285.79K | $25.82M | Add |
| Q4 2025 | 305.47K | $31.52M | Add |
| Q1 2026 | 310.80K | $32.29M | Add |
| Q2 2026 | 319.64K | $34.95M | Add |
| Q3 2026 | 328.31K | $35.94M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PPH and 13F data
PPH (VANECK PHARMACEUTICAL ETF) is a company whose sector is not yet classified in our data. 20 other funds we track also report a position in PPH — the largest reported positions include Avalon Trust Co (US$27.8M), ADAMSBROWN WEALTH CONSULTANTS LLC (US$11.1M), Rye Brook Capital LLC (US$7.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PPH
- Avalon Trust Co 254.16K sh · $27.82M · Q3 2026
- ADAMSBROWN WEALTH CONSULTANTS LLC 101.70K sh · $11.13M · Q3 2026
- Rye Brook Capital LLC 70.25K sh · $7.69M · Q3 2026
- WT Wealth Management 47.80K sh · $5.23M · Q3 2026
- Fortis Group Advisors, LLC 31.59K sh · $3.77M · Q3 2026
- Fluent Financial, LLC 26.90K sh · $2.94M · Q3 2026
More on J.Safra Asset Management Corp
FAQ
How long has J.Safra Asset Management Corp held PPH?
J.Safra Asset Management Corp has disclosed PPH holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
What is J.Safra Asset Management Corp's current position in PPH?
As of Q3 2026, J.Safra Asset Management Corp holds 328.31K shares of PPH (VANECK PHARMACEUTICAL ETF), valued at $35.94M, representing 1.56% of its reported portfolio and ranking #16.
Has J.Safra Asset Management Corp been buying or selling PPH?
In the latest 13F filing (Q3 2026), J.Safra Asset Management Corp increased its position in PPH. The position peaked in Q3 2026 at 328.31K shares.
Which other funds hold PPH?
Other major institutional holders of PPH include Avalon Trust Co, ADAMSBROWN WEALTH CONSULTANTS LLC, Rye Brook Capital LLC, among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.